Where Does Bausch Health Companies Inc (BHC) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Has Fallen -13.68% This Week?

Bausch Health Companies Inc (BHC) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. BHC received an overall rating of 45, which means that it scores higher than 45 percent of all stocks. Bausch Health Companies Inc also achieved a score of 72 in the Drug Manufacturers - Specialty & Generic industry, putting it above 72 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 130 out of the 148 industries.

BHC has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on BHC!

See Full BHC Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Bausch Health Companies Inc Stock Today?

Bausch Health Companies Inc (BHC) stock has fallen -10.96% while the S&P 500 is up 0.28% as of 10:54 AM on Tuesday, Jun 6. BHC has fallen -$0.87 from the previous closing price of $7.94 on volume of 3,801,482 shares. Over the past year the S&P 500 has risen 3.98% while BHC has fallen -23.15%. BHC lost -$0.98 per share the over the last 12 months. Click Here to get the full Stock Report for Bausch Health Companies Inc stock.